SAN FRANCISCO, Jan. 31, 2011 /PRNewswire/ — ClinOps is a
specialized contract research organization with a core service
offering combining expert data management, biostatistics and
specialized clinical services. Emphusion targets development
programs in biotechnology, medical device, and pharmaceutical
industries when these services are a key to success. The company
will change its name to Emphusion effective immediately.
“Through acquisition and internal initiatives, we have grown our
business in three core areas; data management, biostatistics and
clinical services. Through past investment and a recent
infusion of additional capital our primary investor, DW Healthcare
Partners, continues to support our company strategy and new brand
direction. Both our investors and our leadership believe it
is important to have a company name reflecting our full portfolio
of services and our direction for the future,” said David Herron,
CEO & President of ClinOps. “By creating a recognizable brand,
we will emphasize our strength in bringing three key, distinctive
services to our clients assisting them in exceeding their
goals.”
“The name Emphusion, which is derived from emphasis and fusion,
was selected based upon extensive research with customers and
industry experts,” continued Mr. Herron. “The history of this
company is centered around the ideas, experiences and execution of
our employees. The fusion of these components is what our continued
success will be built upon. The new name is appropriate for a
company that sees its primary task as playing a critical role in
assisting to bring emerging companies and products to the global
healthcare marketplace.”
About EmphusionEmphusion integrates ideas, experience and
execution to assist clients in accelerating decisions.
Emphusion’s core service offering combines expert data management,
distinctive biostatistics and specialized clinical services.
Emphusion targets development progr
‘/>”/>